New Products In Brief
This article was originally published in The Gray Sheet
J&J wins ceramic-on-metal hip approval
You may also be interested in...
Tria Beauty postpones IPO. Agendia raises $65 million for cancer tests. Kona Medical gets $30 million for hypertension device development. More financings.
FDA has ordered 21 current and former manufacturers of metal-on-metal total hip replacement systems to conduct post-market surveillance studies of their devices to assess metal toxicity risks.
Johnson & Johnson/DePuy's CoMplete ceramic-on-metal acetabular hip system should be approved by FDA, according to the agency's Orthopedic and Rehabilitation Devices Panel